First Author | Zhang Q | Year | 2013 |
Journal | Invest Ophthalmol Vis Sci | Volume | 54 |
Issue | 8 | Pages | 5376-84 |
PubMed ID | 23868984 | Mgi Jnum | J:214175 |
Mgi Id | MGI:5588527 | Doi | 10.1167/iovs.13-12497 |
Citation | Zhang Q, et al. (2013) IGFBP-3 and TNF-alpha regulate retinal endothelial cell apoptosis. Invest Ophthalmol Vis Sci 54(8):5376-84 |
abstractText | PURPOSE: We hypothesized that loss of insulin-like growth factor binding protein 3 (IGFBP-3) signaling would produce neuronal changes in the retina similar to early diabetes. METHODS: To understand better the role of IGFBP-3 in the retina, IGFBP-3 knockout (KO) mice were evaluated for neuronal, vascular, and functional changes compared to wild-type littermates. We also cultured retinal endothelial cells (REC) in normoglycemia or hyperglycemia to determine the interaction between IGFBP-3 and TNF-alpha, as data indicate that both proteins are regulated by beta-adrenergic receptors and respond antagonistically. We also treated some cells with Compound 49b, a novel beta-adrenergic receptor agonist we have reported previously to regulate IGFBP-3 and TNF-alpha. RESULTS: Electroretinogram analyses showed decreased B-wave and oscillatory potential amplitudes in the IGFBP-3 KO mice, corresponding to increased apoptosis. Retinal thickness and cell numbers in the ganglion cell layer were reduced in the IGFBP-3 KO mice. As expected, loss of IGFBP-3 was associated with increased TNF-alpha levels. When TNF-alpha and IGFBP-3 were applied to REC, they worked antagonistically, with IGFBP-3 inhibiting apoptosis and TNF-alpha promoting apoptosis. Due to their antagonistic nature, results suggest that apoptosis of REC may depend upon which protein (IGFBP-3 versus TNF-alpha) is active. CONCLUSIONS: Taken together, loss of IGFBP-3 signaling results in a phenotype similar to neuronal changes observed in diabetic retinopathy in the early phases, including increased TNF-alpha levels. |